Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension (CRYSTAL-CO)

December 2, 2010 updated by: AstraZeneca

A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With DM Related Complication and Hypertension.

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM patients with DM related complication and hypertension, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Anticipated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
      • Busan, Korea, Republic of
        • Research Site
      • Deagu, Korea, Republic of
        • Research Site
      • Deajeon, Korea, Republic of
        • Research Site
      • Incheon, Korea, Republic of
        • Research Site
      • Kwangju, Korea, Republic of
        • Research Site
      • Seoul, Korea, Republic of
        • Research Site
    • Gyeonggi
      • Bucheon, Gyeonggi, Korea, Republic of
        • Research Site
      • Goyang, Gyeonggi, Korea, Republic of
        • Research Site
      • Guri, Gyeonggi, Korea, Republic of
        • Research Site
      • Sungnam, Gyeonggi, Korea, Republic of
        • Research Site
      • Suwon, Gyeonggi, Korea, Republic of
        • Research Site
    • Kangwon
      • Wonju, Kangwon, Korea, Republic of
        • Research Site
    • Keollabuk
      • Jeonju, Keollabuk, Korea, Republic of
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Type II Diabetes Mellitus patients with Complication and Hypertension

Description

Inclusion Criteria:

  • After diagnosed type II DM, patients received treatment for a least 3 years
  • Type II DM patients with hypertension and its complication.
  • Visited out-patients to care center after 1 Jan. 2008

Exclusion Criteria:

  • Secondary hypertension patients
  • Patients not receiving hypertension medication
  • Patients stopping BP medication, by physician's order
  • Patients currently enrolled in other clinical studies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Type II Diabetes Mellitus patients with Complication and Hypertension

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Attainment rate to the target blood pressure.
Time Frame: After collecting all Patient Record Form.
After collecting all Patient Record Form.

Secondary Outcome Measures

Outcome Measure
Time Frame
Attainment to the target blood pressure will be investigated according to DM related complications.
Time Frame: After collecting all Patient Record Form.
After collecting all Patient Record Form.
Change in the DBP/SBP value will be investigated according to the DM Complication
Time Frame: After collecting all Patient Record Form.
After collecting all Patient Record Form.
Treatment pattern and factors that affect BP control
Time Frame: After collecting all Patient Record Form.
After collecting all Patient Record Form.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Study Director: Joonwoo Bahn, Astrazenca Korea

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2008

Primary Completion (Actual)

March 1, 2009

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

October 9, 2008

First Submitted That Met QC Criteria

October 9, 2008

First Posted (Estimate)

October 10, 2008

Study Record Updates

Last Update Posted (Estimate)

December 3, 2010

Last Update Submitted That Met QC Criteria

December 2, 2010

Last Verified

December 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-CKR-DUM-2008/3

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe